Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Weight Loss

Patient's heartbreaking final words before death

A woman uttered five striking words to her family from her hospital bed before she died of complications arising from her pursuit of a healthier life.

AAP

Trump GLP-1 Pilot Program Could Boost Novo Nordisk & Eli Lilly

Trump’s plan to cover weight loss drugs under Medicaid programs and Medicare Part D plans to could be a major tailwind for LLY and NVO, despite tarrif threats.

MarketBeat

Is Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?

Weight loss drug goliath Eli Lilly just tanked despite posting impressive Q2 results. See what drove the decline and whether the market reaction is overdone.

MarketBeat

From analysis to the latest developments in health,
read the most diverse news in one place.

Portugal tightens rules on weight loss drug prescriptions to prevent misuse

Doctors from only four medical specialties will be able to write prescriptions for injectable drugs that are used to treat type 2 diabetes and obesity but are also popular for weight loss.

Euronews

Tammy Slaton defends decision to drink soda ‘in moderation’ amid weight loss journey

IN FULL

The Independent UK

Daily pill helps patients lose 12% of body weight in early trial

Results of study suggest orforglipron could be a simpler, cheaper alternative to injections

The Guardian - UK

Weight loss jabs and cancer risk: here’s what you need to know about the research so far

So many people in western countries are turning to weight loss drugs such as Wegovy/Ozempic and Mounjaro that concerns have started to emerge about maintaining ready supplies. But with popularity comes scrutiny, and rising demand isn’t the only potential problem with weight loss jabs.

The Conversation

Read news from The Economist, FT, and more,
with one subscription

'Ozempic Penis'? Male Users Claim Genital Growth After Weight Loss Jab Goes Viral

Men using Ozempic report genital growth after weight loss. Doctors say it's fat loss, not drug-related changes, sparking viral debate online.

International Business Times UK

This Blue-Chip Stock Is Cooking Up a Major Growth Catalyst

Eli Lilly is poised for a major boost as new data shows its diabetes drug Mounjaro offers heart health benefits, potentially making it the top choice for patients with Type 2 diabetes.

Barchart

Shares fall after weight loss pill disappoints in trial

IN FULL

The Independent UK

Eli Lilly will seek approval for experimental weight loss pill after promising study

Study participants lost an average of 12.4 per cent of their body weight over 72 weeks.

Euronews

Eli Lilly's Rare Weight Loss Data Miss Could Benefit Competitors

On Thursday, Eli Lilly and Co.’s (NYSE:LLY) weight loss rival Novo Nordisk A/S (NYSE:NVO), along with smaller firms, Terns Pharmaceuticals, Inc. (NASDAQ:TERN), Viking Therapeutics Inc. (NASDAQ:VKTX), and Structure Therapeutics Inc. (NASDAQ:GPCR) are trading higher.

Benzinga

New weight loss pill more ‘tolerable’ than jabs shown to be effective in key trial

The tablet could be a cheaper and more convenient alternative to injections

The Independent UK

High demand expected for new daily weight loss pill

The tablet could be a cheaper and more convenient alternative to injections.

Evening Standard

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Eli Lilly's Closely Watched Obesity Pill Orforglipron Shows Around 12% Weight Loss But Trails Novo Nordisk (UPDATED)

Eli Lilly and Co. (NYSE:LLY) stock plunged on Thursday after the company released topline data from the Phase 3 ATTAIN-1 trial evaluating orforglipron, an investigational oral glucagon-like peptide-1 (GLP-1) receptor agonist.

The Independent UK

I’m a nutrition expert. Here’s what I wish everyone knew about weight loss

If you’re not seeing big changes on the scales, it may be more helpful to shift your focus

The Independent UK

1000-Lb. Sisters’ Tammy Slaton issues bizarre apology for drinking soda

The reality star revealed her dramatic weight loss during an April episode of her TLC show, ‘1000-lb. Sisters’

Evening Standard

EastEnders star reveals her secret to 6.5 stone weight loss: 'Best thing I've ever done'

The 49-year-old has undergone a dramatic transformation over the last two years

Get all your
news in one place.

100’s of premium titles.
One news app.

The Conversation

Five things I wish everyone knew about weight loss – by an expert in nutrition

Weight loss continues to dominate public discourse – often framed as a matter of personal responsibility. But after nearly 15 years working in and around health and nutrition research, I’ve seen how weight is treated differently from almost every other health issue.

The Independent UK

Frustration as people may miss out on weight loss jab because of where they live

IN FULL

The Independent UK

Ozempic could be hurting your gym gains — with potentially dangerous consequences

The Independent UK

The ancient spice that reduces bloating - and could boost weight loss

A diet high in antioxidants can help reduce the risk of heart disease and some other chronic diseases

Evening Standard

OPINION - The real problem with Ozempic? The hell that comes after

It’s not actually that hard to imagine. Have you been on a diet? Have you ever lost weight? If so, the chances are you put that weight right back on again. I’ve done it. Oprah’s done it. Sam Smith have done it. My cat did it (RIP, my boy).

The Independent UK

Thousands of patients miss out on weight loss jab due to NHS ‘postcode lottery’

Doctors have warned that patients are being ‘set up for failure’ due to mismanagement of the rollout of Mounjaro

The Independent UK

Experts reveal potential side effect of Ozempic – and whether we should worry

Researchers found Ozempic-induced weight loss decreased muscle mass by about 10 per cent

1 … 18 19 20 21

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.